Your browser doesn't support javascript.
loading
Results of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy.
Wadsley, Jon; Ainsworth, Gemma; Coulson, Amy Beth; Garcez, Kate; Moss, Laura; Newbold, Kate; Farnell, Kate; Swain, Jayne; Howard, Helen; Beasley, Matthew; Weaver, Andrew; Wood, Katie; Marshall, Jennifer; Griffin, Matthew; Pascoe, Abigail; Du, Yong; Taprogge, Jan; Flux, Glenn; Brown, Sarah.
Afiliação
  • Wadsley J; Weston Park Hospital, Sheffield, United Kingdom.
  • Ainsworth G; Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom.
  • Coulson AB; Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom.
  • Garcez K; Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Moss L; Velindre Cancer Centre, Cardiff, United Kingdom.
  • Newbold K; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Farnell K; Butterfly Thyroid Cancer Trust, NCCC Freeman Hospital, Newcastle, United Kingdom.
  • Swain J; Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom.
  • Howard H; Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom.
  • Beasley M; Bristol Haematology and Oncology Centre, Bristol, United Kingdom.
  • Weaver A; Oxford Churchill Hospital, Oxford, United Kingdom.
  • Wood K; Royal Surrey County Hospital, Guildford, United Kingdom.
  • Marshall J; University Hospital Southampton, Southampton, United Kingdom.
  • Griffin M; Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
  • Pascoe A; Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
  • Du Y; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Taprogge J; Joint Department of Physics, Royal Marsden NHS Foundation Trust, Sutton, United Kingdom.
  • Flux G; The Institute of Cancer Research, London, United Kingdom.
  • Brown S; Joint Department of Physics, Royal Marsden NHS Foundation Trust, Sutton, United Kingdom.
Thyroid ; 33(9): 1119-1123, 2023 09.
Article em En | MEDLINE | ID: mdl-37565288
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Glândula Tireoide / Adenocarcinoma / Iodo / Antineoplásicos Limite: Humans Idioma: En Revista: Thyroid Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Glândula Tireoide / Adenocarcinoma / Iodo / Antineoplásicos Limite: Humans Idioma: En Revista: Thyroid Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido